CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of destructive behavior.
3.4.1.2. Increase in number of substances abuse.
3.4.1.3. Increase in demand for behavioral health services.
3.4.2. Restraints
3.4.2.1. Availability of alternative health therapies for behavioral disorders
3.4.2.2. High cost of service associated with the behavioral healthcare
3.4.3. Opportunities
3.4.3.1. Introduction of telehealth for behavioral health care
CHAPTER 4: BEHAVIORAL HEALTH MARKET, BY DISORDER
4.1. Overview
4.1.1. Market size and forecast
4.2. Alcohol Use Disorders
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Substance Abuse Disorders
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Eating Disorders
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. ADHD
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: BEHAVIORAL HEALTH MARKET, BY SERVICE
5.1. Overview
5.1.1. Market size and forecast
5.2. Emergency Mental Health Services
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Outpatient Counselling
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Home-based Treatment Services
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Inpatient Hospital Treatment Services
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Other Services
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: BEHAVIORAL HEALTH MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. Pediatric
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Adult
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Geriatric
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BEHAVIORAL HEALTH MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Disorder
7.2.3. Market size and forecast, by Service
7.2.4. Market size and forecast, by Age Group
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Disorder
7.2.5.1.2. Market size and forecast, by Service
7.2.5.1.3. Market size and forecast, by Age Group
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Disorder
7.2.5.2.2. Market size and forecast, by Service
7.2.5.2.3. Market size and forecast, by Age Group
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Disorder
7.2.5.3.2. Market size and forecast, by Service
7.2.5.3.3. Market size and forecast, by Age Group
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Disorder
7.3.3. Market size and forecast, by Service
7.3.4. Market size and forecast, by Age Group
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Disorder
7.3.5.1.2. Market size and forecast, by Service
7.3.5.1.3. Market size and forecast, by Age Group
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Disorder
7.3.5.2.2. Market size and forecast, by Service
7.3.5.2.3. Market size and forecast, by Age Group
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Disorder
7.3.5.3.2. Market size and forecast, by Service
7.3.5.3.3. Market size and forecast, by Age Group
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Disorder
7.3.5.4.2. Market size and forecast, by Service
7.3.5.4.3. Market size and forecast, by Age Group
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Disorder
7.3.5.5.2. Market size and forecast, by Service
7.3.5.5.3. Market size and forecast, by Age Group
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Disorder
7.3.5.6.2. Market size and forecast, by Service
7.3.5.6.3. Market size and forecast, by Age Group
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Disorder
7.4.3. Market size and forecast, by Service
7.4.4. Market size and forecast, by Age Group
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Disorder
7.4.5.1.2. Market size and forecast, by Service
7.4.5.1.3. Market size and forecast, by Age Group
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Disorder
7.4.5.2.2. Market size and forecast, by Service
7.4.5.2.3. Market size and forecast, by Age Group
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by Disorder
7.4.5.3.2. Market size and forecast, by Service
7.4.5.3.3. Market size and forecast, by Age Group
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by Disorder
7.4.5.4.2. Market size and forecast, by Service
7.4.5.4.3. Market size and forecast, by Age Group
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Market size and forecast, by Disorder
7.4.5.5.2. Market size and forecast, by Service
7.4.5.5.3. Market size and forecast, by Age Group
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Disorder
7.5.3. Market size and forecast, by Service
7.5.4. Market size and forecast, by Age Group
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Disorder
7.5.5.1.2. Market size and forecast, by Service
7.5.5.1.3. Market size and forecast, by Age Group
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Disorder
7.5.5.2.2. Market size and forecast, by Service
7.5.5.2.3. Market size and forecast, by Age Group
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Disorder
7.5.5.3.2. Market size and forecast, by Service
7.5.5.3.3. Market size and forecast, by Age Group
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Disorder
7.5.5.4.2. Market size and forecast, by Service
7.5.5.4.3. Market size and forecast, by Age Group
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Centene Corporation PLC
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Elevance Health, LLC
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Ascension
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Welligent Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Acadia Healthcare Co.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Civitas Solutions Inc. (Sevita)
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. Behavioral Health Services Inc.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Pyramid Healthcare, Inc.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Bright Harbor Healthcare
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Core Solutions Inc.
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.11. Universal Health Services, Inc.
9.11.1. Company overview
9.11.2. Key executives
9.11.3. Company snapshot
9.11.4. Operating business segments
9.11.5. Product portfolio
9.11.6. Business performance
9.12. Oracle Corporation
9.12.1. Company overview
9.12.2. Key executives
9.12.3. Company snapshot
9.12.4. Operating business segments
9.12.5. Product portfolio
9.12.6. Business performance
9.12.7. Key strategic moves and developments
| ※参考情報 行動医療とは、個人の行動、感情、思考の健康に焦点を当てる医療の一分野です。身体的な健康だけでなく、心や行動の側面も重要であるという考え方に基づいています。行動医療は精神的な健康状態の改善を目指し、患者が抱えるさまざまな問題に対処するための手法や技術を提供します。 行動医療にはいくつかの種類があります。まず、心理療法が挙げられます。これは専門家が患者と対話し、心理的な問題や情緒的な課題を解決する手法です。さまざまなアプローチがあり、認知行動療法や精神分析療法などがあります。認知行動療法は、非合理的な思考パターンを変えることによって、行動や感情にもポジティブな影響を及ぼすことを目指します。 次に、薬物療法も行動医療の重要な一部です。抗うつ薬や抗不安薬、抗精神病薬などが含まれます。これらの薬は脳内の化学物質に影響を与え、症状を軽減することが目的です。しばしば心理療法と併用され、患者の生活の質を向上させる効果を持ちます。 また、行動療法も重要なアプローチの一つです。この手法は、特定の問題行動を修正するための訓練を行います。たとえば、子どもの行動問題や依存症に対して行われることがあります。行動療法では、ポジティブな行動を強化し、ネガティブな行動を減少させるための介入が行われます。 さらに、グループ療法や家族療法も行動医療の重要な側面です。これらのアプローチは、患者が他者と共有することで精神的な支援を得る方法です。グループ療法では、同じような問題を持つ人々が集まり、相互に支え合う環境を作ります。一方、家族療法では、家族全体が治療の一環として関与し、それぞれの役割や関係性を見直すことが目的です。 行動医療の用途は多岐に渡ります。主にストレス、不安、うつ病、摂食障害、依存症、人格障害など、さまざまな精神的健康問題の治療に使われます。また、ストレス管理や対人関係の改善、自己理解を深めるためにも応用されます。行動医療は、患者のニーズに合わせて柔軟にアプローチを選ぶことができるため、さまざまな状況や背景に対応可能です。 最近では、デジタル技術の進化に伴い、行動医療も変化を遂げています。オンライン therapy やアプリを使用したセルフケアの手法が増え、患者がいつでもどこでもサポートを受けられる環境が整いつつあります。これにより、より多くの人が手軽にメンタルヘルスケアにアクセスできるようになりました。 また、人工知能（AI）を活用したツールの開発も進んでいます。AIは症状のモニタリングや患者の行動パターンを分析する能力を持ち、医師がより適切な治療法を選択するための情報提供が期待されています。ただし、これらの技術はあくまで補助的な役割であり、専門家の介入が必要です。 行動医療は個々の病状に合わせた個別化されたアプローチを提供できるため、今後ますます重要が増す分野です。患者が直面する心の問題に対して、適切なサポートと治療を提供することで、より健康的な生活を促進する役割を果たしています。行動医療は、精神的な健康を維持し、質の高い生活を送るための重要な手段であると言えるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
